Lexaria Bioscience (LEXX) Tax Provisions (2025 - 2026)

Lexaria Bioscience's (LEXX) quarterly Tax Provisions came in at $2598.0 in Q1 2026, up 45.06% quarter-over-quarter from $1791.0 in Q4 2025.

Lexaria Bioscience (LEXX) Tax Provisions (2025 - 2026) Analysis & Trends

Lexaria Bioscience has disclosed Tax Provisions across 2 years of filings, most recently posting $2598.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -11.20 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -859,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 216,000.00
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 221.50 Mn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Lexaria Bioscience 7.17 Mn 1.65 Mn 20,000.00 2,598.00

Historic Data

Download Data
DateValue
Feb 28, 2026 2,598.00
Nov 30, 2025 1,791.00